肿瘤微环境与耐药性的纳米药物递送进展——来自特刊“靶向肿瘤微环境并同时克服耐药特性的纳米药物递送系统”的见解
Advances in Nano-Drug Delivery for Tumor Microenvironment and Drug Resistance-Insights from the Special Issue "Nano-Drug Delivery Systems for Targeting the Tumor Microenvironment and Simultaneously Overcoming Drug Resistance Properties".
作者信息
Silva Patrícia M A, Queirós Odília
机构信息
UNIPRO-Oral Pathology and Rehabilitation Research Unit, University Institute of Health Sciences (IUCS-CESPU), 4585-116 Gandra, Portugal.
Associate Laboratory i4HB-Institute for Health and Bioeconomy, University Institute of Health Sciences-CESPU, 4585-116 Gandra, Portugal.
出版信息
Pharmaceutics. 2025 Jul 21;17(7):942. doi: 10.3390/pharmaceutics17070942.
Abstract
Cancer continues to pose a major global health burden [...].
摘要
癌症仍然是一个重大的全球健康负担[……]。
相似文献
1
Advances in Nano-Drug Delivery for Tumor Microenvironment and Drug Resistance-Insights from the Special Issue "Nano-Drug Delivery Systems for Targeting the Tumor Microenvironment and Simultaneously Overcoming Drug Resistance Properties".肿瘤微环境与耐药性的纳米药物递送进展——来自特刊“靶向肿瘤微环境并同时克服耐药特性的纳米药物递送系统”的见解
Pharmaceutics. 2025 Jul 21;17(7):942. doi: 10.3390/pharmaceutics17070942.
2
Nano-Drug Carriers for Targeted Therapeutic Approaches in Oral Cancer: A Systematic Review.用于口腔癌靶向治疗方法的纳米药物载体：一项系统综述。
J Maxillofac Oral Surg. 2024 Aug;23(4):763-771. doi: 10.1007/s12663-024-02251-z. Epub 2024 Jun 21.
3
Advancing Amyloid Aggregation Research: A Focus on Innovative Therapies, Molecular Modeling and Nano-Delivery Systems in Alzheimer's Disease.推进淀粉样蛋白聚集研究：聚焦阿尔茨海默病的创新疗法、分子建模与纳米递送系统
Curr Drug Targets. 2025 Jun 24. doi: 10.2174/0113894501388678250618070927.
4
Platelet Membrane-Coated Poly (Lactic-Co-Glycolic Acid) Nanoparticles as a Targeting Drug Delivery System for Multidrug-Resistant Breast Cancer.血小板膜包被的聚（乳酸-乙醇酸）纳米粒作为多药耐药乳腺癌的靶向给药系统
Int J Nanomedicine. 2025 Jul 2;20:8529-8545. doi: 10.2147/IJN.S517753. eCollection 2025.
5
Tumor therapy by targeting extracellular hydroxyapatite using novel drugs: A paradigm shift.靶向细胞外羟基磷灰石的新型药物肿瘤治疗：范式转变。
Cancer Med. 2024 Feb;13(3):e6812. doi: 10.1002/cam4.6812. Epub 2024 Jan 18.
6
An update on cancer stem cell survival pathways involved in chemoresistance in triple-negative breast cancer.三阴性乳腺癌中与化疗耐药相关的癌症干细胞存活途径的最新进展。
Future Oncol. 2025 Mar;21(6):715-735. doi: 10.1080/14796694.2025.2461443. Epub 2025 Feb 12.
7
Role of borneol as enhancer in drug formulation: A review.冰片在药物制剂中作为增溶剂的作用：综述。
Chin Herb Med. 2024 May 17;17(3):473-483. doi: 10.1016/j.chmed.2024.04.003. eCollection 2025 Jul.
8
Salvia miltiorrhiza Bunge (Danshen) based nano-delivery systems for anticancer therapeutics.丹参（Danshen）为基础的纳米递药系统用于抗癌治疗。
Phytomedicine. 2024 Jun;128:155521. doi: 10.1016/j.phymed.2024.155521. Epub 2024 Mar 8.
9
Natural macromolecules polysaccharide-based drug delivery systems targeting tumor necrosis factor alpha receptor for the treatment of cancer: A review.靶向肿瘤坏死因子α受体用于癌症治疗的天然高分子多糖基药物递送系统：综述
Int J Biol Macromol. 2025 Jul;318(Pt 4):145145. doi: 10.1016/j.ijbiomac.2025.145145. Epub 2025 Jun 20.
10
PCL-PEtOx-based Crystalline-core Micelles for the Targeted Delivery of Paclitaxel and Trabectedin in Ovarian Cancer Therapy.基于聚己内酯-聚乙交酯的结晶核胶束用于卵巢癌治疗中紫杉醇和曲贝替定的靶向递送
Acta Biomater. 2025 Apr 28. doi: 10.1016/j.actbio.2025.04.050.
本文引用的文献
1
Contribution of tumor microenvironment (TME) to tumor apoptosis, angiogenesis, metastasis, and drug resistance.肿瘤微环境（TME）对肿瘤细胞凋亡、血管生成、转移及耐药性的作用。
Med Oncol. 2025 Mar 14;42(4):108. doi: 10.1007/s12032-025-02675-8.
2
Molecular mechanisms and therapeutic strategies in overcoming chemotherapy resistance in cancer.癌症中克服化疗耐药性的分子机制与治疗策略
Mol Biomed. 2025 Jan 6;6(1):2. doi: 10.1186/s43556-024-00239-2.
3
Biologically based strategies for overcoming in vivo barriers with functional nano-delivery systems.利用功能纳米递药系统克服体内障碍的基于生物学的策略。
J Biochem Mol Toxicol. 2024 Aug;38(8):e23782. doi: 10.1002/jbt.23782.
4
Tumor microenvironment signaling and therapeutics in cancer progression.肿瘤微环境信号与癌症进展中的治疗策略。
Cancer Commun (Lond). 2023 May;43(5):525-561. doi: 10.1002/cac2.12416. Epub 2023 Apr 2.
5
Understanding the tumor immune microenvironment (TIME) for effective therapy.理解肿瘤免疫微环境（TIME）以实现有效的治疗。
Nat Med. 2018 May;24(5):541-550. doi: 10.1038/s41591-018-0014-x. Epub 2018 Apr 23.
6
Cancer nanomedicine: progress, challenges and opportunities.癌症纳米医学：进展、挑战与机遇。
Nat Rev Cancer. 2017 Jan;17(1):20-37. doi: 10.1038/nrc.2016.108. Epub 2016 Nov 11.
7
Nanotheranostics for personalized medicine.用于个性化医学的纳米诊疗剂。
Adv Drug Deliv Rev. 2012 Oct;64(13):1394-416. doi: 10.1016/j.addr.2012.06.006. Epub 2012 Jun 21.
Zotero 插件